AVENIR CORP 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:42 pm Purchase | 2023-12-31 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 3,051,402 6.870% | 604,313 (+24.70%) | Filing |
| 2023-02-14 1:08 pm Purchase | 2022-12-31 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,447,089 5.610% | 259,307 (+11.85%) | Filing |
| 2022-08-11 08:39 am Purchase | 2022-07-26 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,187,782 5.020% | 30,949 (+1.43%) | Filing |
| 2022-06-27 5:34 pm Sale | 2022-05-26 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,156,833 4.950% | -20,313 (-0.93%) | Filing |
| 2022-04-22 5:34 pm Purchase | 2022-03-22 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,177,146 5.000% | 89,075 (+4.27%) | Filing |
| 2022-01-07 5:10 pm Sale | 2021-12-20 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,088,071 4.800% | -156,264 (-6.96%) | Filing |
| 2021-12-13 5:01 pm Purchase | 2021-11-16 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,244,335 5.160% | 2,244,335 (New Position) | Filing |